Endogenous Ochrobactrum anthropi endophthalmitis.
OBJECTIVE
To describe bilateral endogenous endophthalmitis caused by Ochrobactrum anthropi in a partially immunosuppressed patient who had undergone central venous access for hyperalimentation and home intravenous therapy.


METHODS
Case report.


RESULTS
Blood cultures were positive for O anthropi. Vitreous cultures grew a gram-variable bacillus. The patient's ocular and systemic condition markedly improved after intravitreal antibiotics and systemic ciprofloxacin.


CONCLUSIONS
Ochrobactrum anthropi may cause endogenous endophthalmitis in patients with a history of indwelling catheters for venous access or other permanent medical devices.
Berman
A J
AJ
Barnes Retina Institute, Washington University School of Medicine, St Louis, MO 63110, USA.
Del Priore
L V
LV
Fischer
C K
CK
D000368:Aged; D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents / Q000627:therapeutic use; D016470:Bacteremia / Q000188:drug therapy / Q000209:etiology; D002405:Catheterization, Central Venous / Q000009:adverse effects*; D002408:Catheters, Indwelling / Q000009:adverse effects*; D002939:Ciprofloxacin / Q000627:therapeutic use; D004359:Drug Therapy, Combination / Q000627:therapeutic use; D009877:Endophthalmitis / Q000188:drug therapy / Q000382:microbiology* / Q000473:pathology; D004866:Equipment Contamination; D005260:Female; D006088:Gram-Negative Aerobic Bacteria / Q000302:isolation & purification*; D016905:Gram-Negative Bacterial Infections / Q000188:drug therapy / Q000473:pathology; D006801:Humans; D010289:Parenteral Nutrition, Total; D014821:Vitrectomy; D014822:Vitreous Body / Q000382:microbiology
D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents; D002939:Ciprofloxacin